<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>晶泰科技 on AI内参</title>
    <link>http://192.168.50.247:1313/tags/%E6%99%B6%E6%B3%B0%E7%A7%91%E6%8A%80/</link>
    <description>Recent content in 晶泰科技 on AI内参</description>
    <generator>Hugo</generator>
    <language>zh-cn</language>
    <lastBuildDate>Tue, 17 Jun 2025 20:20:00 +0800</lastBuildDate>
    <atom:link href="http://192.168.50.247:1313/tags/%E6%99%B6%E6%B3%B0%E7%A7%91%E6%8A%80/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>AI制药：十年浮沉，从幻想到务实的新基建</title>
      <link>http://192.168.50.247:1313/articles/article-20250617202000328-0/</link>
      <pubDate>Tue, 17 Jun 2025 20:20:00 +0800</pubDate>
      <guid>http://192.168.50.247:1313/articles/article-20250617202000328-0/</guid>
      <description>过去十年，AI制药经历了从颠覆性愿景到务实发展的剧烈转变，初期由资本狂热推动，但在临床试验屡遭挫折后，行业开始反思并回归制药本质。头部企业或积极拓展AI在材料、农业等新领域的应用，或坚守制药主业并寻求模式创新，共同将AI定位为赋能新药研发的“新基建”，预示着一个更加理性且充满潜力的二次进化阶段。</description>
    </item>
  </channel>
</rss>
